SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Repeated open-market purchases by CEO Troy Wilson, including another 100,000-share buy, are driving attention and are being viewed by traders as a strong management-confidence signal. The community is broadly bullish and discussing short covering, a potential Kyowa Kirin acquisition, and KOMZIFTIs launch momentum, though some remain cautious about valuation and biotech execution risk.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The token is drawing attention amid a prolonged collapse from its launch-era peak, with traders largely debating whether it was a Trump-family-linked pump-and-dump and criticizing its lack of utility. A smaller bullish group is promoting dip-buying and a potential rebound, but bearish sentiment dominates.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canadas sale of a minority stake in Aeroplan, combined with stronger-than-expected quarterly results and resilient travel demand, has focused attention on value unlocking, debt reduction and accelerated share buybacks. Traders are largely bullish, though some remain concerned about elevated fuel and labor costs and the airlines ongoing net debt burden.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

The Ninth Circuits ruling that sports-event contracts are bets rather than federally regulated swaps is being viewed as a regulatory win for DraftKings, potentially limiting Kalshi and other prediction-market competition and strengthening licensed sportsbooks moat. Traders are broadly bullish on the implications, though some remain cautious about the circuit split, possible Supreme Court review, prediction-market execution, and the stocks history of failing to hold gains.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforces strong quarterly results, raised outlook and expanded Anthropic partnership through Claudeforce have driven a sharp re-rating and renewed confidence that AI can augment rather than replace enterprise SaaS. Traders are broadly bullish and citing short covering and a broader software rotation, while skeptics argue the move is overextended and that buybacks, investments and acquisitions flatter underlying organic growth.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Natural-gas storage injections, elevated production and Freeport LNG maintenance are driving the dominant bearish discussion around BOIL, with traders arguing these supply factors are outweighing summer heat and power demand. Others anticipate a rebound if upcoming storage draws strengthen or Freeport exports recover, while many stress that contango and leveraged decay make BOIL a short-term trading vehicle rather than a long-term hold.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is caught in a tug-of-war as traders debate whether the recent crude oil rally is a geopolitical mirage or a real supply crisis, with the community split between those citing relentless bearish supply headlines and those pointing to persistent inventory draws and war risk. The leveraged ETF is getting whipped around by every headline on the Strait of Hormuz, OPEC+ output, and U.S.-Iran talks, creating heavy volatility and sharp positioning shifts.

ETF Opportunities Trust - T-Rex 2X Long MSTR Daily Target ETF

T-Rex 2X Long MSTR Daily Target ETF

The scheduled 1-for-10 reverse split has become the main focus, with traders discussing its impact on share prices, options settlement, liquidity and the ETFs repeated reverse-split history. The broader debate centers on whether weakness reflects Bitcoin and MSTR volatility or MSTUs structural leverage and daily decay, prompting both dip-buying and short-selling.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Treasury Secretary Scott Bessents expanded long-end bond buyback plan is driving attention, with traders debating whether it can suppress elevated Treasury yields or merely provide temporary support. The discussion is further complicated by Fed Chair Kevin Warshs hawkish stance on persistent inflation, producing a split between traders expecting a bond-market short squeeze and those warning that fiscal pressures and higher-for-longer rates will keep TLT under pressure.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Updated Phase III HARMONi overall-survival data for ivonescimab, showing more consistent benefit across Western and Asian patients, is driving attention ahead of the FDAs scheduled decision. Traders remain divided: bulls see improving evidence and insider buying as supportive of approval, while bears point to the earlier statistical OS miss, reliance on China-led data, and potential dilution or funding needs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


mominaabid

Momina Abid